BridgeMD
New treatment option for Intracerebral Hemorrhage
Official title Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
ClinicalTrials.gov ID: NCT05504941
What this study is testing
- What it's testing
- This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of an acute spontaneous ICH based on non-contrast CT
- Time from symptom onset to anticipated start of cerebral DSA of under 3 hours
- Agreement of the treating physician to perform DSA
- Informed consent documented by signature or fulfilling the criteria for emergency consent procedures (deferral of consent)
You likely can't join if
- High probability that the etiology of the bleeding is a ruptured aneurysm, an arteriovenous malformation or an amyloid angiopathy as judged by the...
- Any time critical surgical or minimal invasive intervention is planned
- Evidence of an ongoing pregnancy, a negative pregnancy test is mandatory in all persons of childbearing potential
- Contraindications against the use of iodine contrast media
- Known severe kidney insufficiency (Glomerular filtration rate \< 30 ml/min)
The study team makes the final eligibility decision.
Where it's taking place
- Basel, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basel, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.